Free Trial

IGC Pharma (IGC) Earnings Date, Estimates & Call Transcripts

IGC Pharma logo
$0.28 -0.05 (-13.83%)
Closing price 04/17/2025 03:58 PM Eastern
Extended Trading
$0.28 0.00 (-1.42%)
As of 04/17/2025 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IGC Pharma Earnings Summary

Latest
Earnings Date
Nov. 12Estimated
Consensus EPS
(Nov. 12)
-$0.03
Actual EPS
(Nov. 12)
-$0.02 Beat By $0.01
Actual Revenue
(Nov. 12)
$0.41M

IGC Pharma posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.02, which topped analysts' consensus estimates of -$0.03 by $0.01. Quarterly revenue was reported to be $0.41 million, above analyst estimates of $0.29 million. With a trailing EPS of -$0.11, IGC Pharma's earnings are expected to decrease next year, from ($0.11) to ($0.12) per share.

Nov. 12 Earnings Resources

Get IGC Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IGC Pharma and other key companies, straight to your inbox.

Sign Up

IGC Pharma Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.11) EPS
Next Year EPS Consensus Estimate
($0.12) EPS

IGC Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024--$0.03-$0.02+$0.01-$0.02$0.29M$0.41M

IGC Pharma Earnings - Frequently Asked Questions

IGC Pharma (NYSEMKT:IGC) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on IGC's earnings history.

In the previous quarter, IGC Pharma (NYSEMKT:IGC) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.03) by $0.01. Learn more on analysts' earnings estimate vs. IGC's actual earnings.

IGC Pharma (NYSEMKT:IGC) has a recorded annual revenue of $1.24 million.

IGC Pharma (NYSEMKT:IGC) has a recorded net income of -$13 million. IGC has generated -$0.11 earnings per share over the last four quarters.

IGC Pharma's earnings are expected to decrease from ($0.11) per share to ($0.12) per share in the next year.

More Earnings Resources from MarketBeat



This page (NYSEMKT:IGC) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners